GB1483165A - Pharmaceutical compositions and a process for the preparation thereof - Google Patents
Pharmaceutical compositions and a process for the preparation thereofInfo
- Publication number
- GB1483165A GB1483165A GB4978875A GB4978875A GB1483165A GB 1483165 A GB1483165 A GB 1483165A GB 4978875 A GB4978875 A GB 4978875A GB 4978875 A GB4978875 A GB 4978875A GB 1483165 A GB1483165 A GB 1483165A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compositions
- pharmaceutical compositions
- dec
- weight
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- 229940121363 anti-inflammatory agent Drugs 0.000 abstract 2
- 239000002260 anti-inflammatory agent Substances 0.000 abstract 2
- 230000003110 anti-inflammatory effect Effects 0.000 abstract 2
- CGIGDMFJXJATDK-UHFFFAOYSA-N indomethacin Chemical compound CC1=C(CC(O)=O)C2=CC(OC)=CC=C2N1C(=O)C1=CC=C(Cl)C=C1 CGIGDMFJXJATDK-UHFFFAOYSA-N 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 abstract 2
- BSYNRYMUTXBXSQ-UHFFFAOYSA-N Aspirin Chemical compound CC(=O)OC1=CC=CC=C1C(O)=O BSYNRYMUTXBXSQ-UHFFFAOYSA-N 0.000 abstract 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 abstract 1
- NNJVILVZKWQKPM-UHFFFAOYSA-N Lidocaine Chemical compound CCN(CC)CC(=O)NC1=C(C)C=CC=C1C NNJVILVZKWQKPM-UHFFFAOYSA-N 0.000 abstract 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 abstract 1
- JZFPYUNJRRFVQU-UHFFFAOYSA-N Niflumic acid Chemical compound OC(=O)C1=CC=CN=C1NC1=CC=CC(C(F)(F)F)=C1 JZFPYUNJRRFVQU-UHFFFAOYSA-N 0.000 abstract 1
- 229960001138 acetylsalicylic acid Drugs 0.000 abstract 1
- 229910052783 alkali metal Inorganic materials 0.000 abstract 1
- 150000001340 alkali metals Chemical class 0.000 abstract 1
- 239000002775 capsule Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000008298 dragée Substances 0.000 abstract 1
- 239000007941 film coated tablet Substances 0.000 abstract 1
- 229960000905 indomethacin Drugs 0.000 abstract 1
- 229960004194 lidocaine Drugs 0.000 abstract 1
- 229910052744 lithium Inorganic materials 0.000 abstract 1
- 229960005015 local anesthetics Drugs 0.000 abstract 1
- 229960000916 niflumic acid Drugs 0.000 abstract 1
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 abstract 1
- 229960002895 phenylbutazone Drugs 0.000 abstract 1
- VYMDGNCVAMGZFE-UHFFFAOYSA-N phenylbutazonum Chemical compound O=C1C(CCCC)C(=O)N(C=2C=CC=CC=2)N1C1=CC=CC=C1 VYMDGNCVAMGZFE-UHFFFAOYSA-N 0.000 abstract 1
- 229960001860 salicylate Drugs 0.000 abstract 1
- YGSDEFSMJLZEOE-UHFFFAOYSA-M salicylate Chemical compound OC1=CC=CC=C1C([O-])=O YGSDEFSMJLZEOE-UHFFFAOYSA-M 0.000 abstract 1
- 229960004889 salicylic acid Drugs 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
- 229910052708 sodium Inorganic materials 0.000 abstract 1
- 239000011734 sodium Substances 0.000 abstract 1
- 239000007940 sugar coated tablet Substances 0.000 abstract 1
- 239000000829 suppository Substances 0.000 abstract 1
- 239000003826 tablet Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HURI000556 HU170329B (enrdf_load_stackoverflow) | 1974-12-12 | 1974-12-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1483165A true GB1483165A (en) | 1977-08-17 |
Family
ID=11000967
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB4978875A Expired GB1483165A (en) | 1974-12-12 | 1975-12-04 | Pharmaceutical compositions and a process for the preparation thereof |
Country Status (14)
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4228161A (en) | 1979-03-28 | 1980-10-14 | Merck & Co., Inc. | Anti-inflammatory combination having reduced ulcerogenicity |
| EP0036145A1 (en) * | 1980-03-07 | 1981-09-23 | INTERx RESEARCH CORPORATION | An orally administered drug form comprising a polar bioactive agent and an adjuvant |
| EP0031561A3 (en) * | 1979-12-20 | 1982-08-11 | Merck & Co. Inc. | A rectally administered drug form comprising a drug and an adjuvant |
| RU2226091C1 (ru) * | 2002-08-27 | 2004-03-27 | Открытое акционерное общество "Биосинтез" | Ректальные суппозитории, обладающие противовоспалительным и болеутоляющим действием |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE863935A (fr) * | 1977-02-26 | 1978-08-14 | Basf Ag | Utilisation de l'ether 1,2-propylene-glycol-1-n-propylique comme solvant pour preparations pharmaceutiques |
| CA1211374A (en) * | 1982-05-14 | 1986-09-16 | Eszter Cholnoky | Pharmaceutical compositions containing more active ingredients |
| MX2013008995A (es) * | 2013-08-02 | 2014-03-24 | Raam De Sahuayo S A De C V Lab | Composicion farmaceutica para el tratamiento del dolor. |
| WO2024221023A1 (en) * | 2023-04-20 | 2024-10-24 | Gie Christo | Anti-inflammatory, analgesic and antipyretic suppository |
-
1974
- 1974-12-12 HU HURI000556 patent/HU170329B/hu not_active IP Right Cessation
-
1975
- 1975-12-03 AT AT919575A patent/AT342191B/de not_active IP Right Cessation
- 1975-12-04 GB GB4978875A patent/GB1483165A/en not_active Expired
- 1975-12-04 CY CY109875A patent/CY1098A/xx unknown
- 1975-12-05 DE DE19752554902 patent/DE2554902C3/de not_active Expired
- 1975-12-08 BE BE162549A patent/BE836400A/xx not_active IP Right Cessation
- 1975-12-11 JP JP14789575A patent/JPS5182715A/ja active Pending
- 1975-12-11 FR FR7537976A patent/FR2293938A1/fr active Granted
- 1975-12-11 DD DD19005275A patent/DD121711A5/xx unknown
- 1975-12-12 NL NL7514554A patent/NL7514554A/xx active Search and Examination
-
1980
- 1980-11-19 KE KE310180A patent/KE3101A/xx unknown
- 1980-12-01 GT GT198066593A patent/GT198066593A/es unknown
- 1980-12-18 HK HK70580A patent/HK70580A/xx unknown
-
1981
- 1981-12-30 MY MY8100249A patent/MY8100249A/xx unknown
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4228161A (en) | 1979-03-28 | 1980-10-14 | Merck & Co., Inc. | Anti-inflammatory combination having reduced ulcerogenicity |
| EP0031561A3 (en) * | 1979-12-20 | 1982-08-11 | Merck & Co. Inc. | A rectally administered drug form comprising a drug and an adjuvant |
| DK156121B (da) * | 1979-12-20 | 1989-06-26 | Merck & Co Inc | Fremgangsmaade til fremstilling af et rectalt administrerbart suppositorium indeholdende et adjuvans |
| EP0036145A1 (en) * | 1980-03-07 | 1981-09-23 | INTERx RESEARCH CORPORATION | An orally administered drug form comprising a polar bioactive agent and an adjuvant |
| RU2226091C1 (ru) * | 2002-08-27 | 2004-03-27 | Открытое акционерное общество "Биосинтез" | Ректальные суппозитории, обладающие противовоспалительным и болеутоляющим действием |
Also Published As
| Publication number | Publication date |
|---|---|
| KE3101A (en) | 1981-02-13 |
| DE2554902B2 (enrdf_load_stackoverflow) | 1978-04-06 |
| HU170329B (enrdf_load_stackoverflow) | 1977-05-28 |
| JPS5182715A (ja) | 1976-07-20 |
| NL7514554A (nl) | 1976-06-15 |
| DE2554902A1 (de) | 1976-06-16 |
| FR2293938A1 (fr) | 1976-07-09 |
| AT342191B (de) | 1978-03-28 |
| MY8100249A (en) | 1981-12-31 |
| GT198066593A (es) | 1982-05-25 |
| DE2554902C3 (de) | 1978-12-14 |
| DD121711A5 (enrdf_load_stackoverflow) | 1976-08-20 |
| CY1098A (en) | 1981-04-17 |
| HK70580A (en) | 1980-12-24 |
| FR2293938B1 (enrdf_load_stackoverflow) | 1979-06-29 |
| BE836400A (fr) | 1976-04-01 |
| ATA919575A (de) | 1977-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1274271A (en) | Improvements in or relating to propionic acid derivatives | |
| GB1483165A (en) | Pharmaceutical compositions and a process for the preparation thereof | |
| GB1178034A (en) | Hydroxy-Cyclohexylamines | |
| GB1015787A (en) | Tris-(p-methoxyphenyl)ethylene derivatives | |
| GB1192701A (en) | Novel Thiazole Derivatives, the preparation thereof and Compositions containing the same | |
| IE33371L (en) | Protozoacids; aminoguanidine derivatives | |
| GB1153640A (en) | A Carnitin Salt | |
| GB1131164A (en) | Novel halogen-substituted tetrahydroquinazoline derivatives, their preparation and compositions containing them | |
| GB1204172A (en) | Pharmaceutical compositions | |
| GB1518333A (en) | Pharmaceutical compositions containing a ypsilon-resorcylic acid derivative | |
| GB1499720A (en) | Method of preventing thrombosis | |
| GB1352392A (en) | Phenylisopropylamine derivatives | |
| IE34139B1 (en) | 4-phenyl-butric acid derivatives | |
| GB1177411A (en) | Improvements in and relating to Pharmaceutical Compositions | |
| ES342394A1 (es) | Procedimiento para la produccion de nuevas 2-bencilamino-i-mida-zolinas-(2). | |
| GB1268523A (en) | Dihydrofuran derivatives, the preparation thereof, and compositions containing the same | |
| GB1301857A (enrdf_load_stackoverflow) | ||
| GB909688A (en) | 5-substituted-2,4-disulfamyl (halo) acylanilides | |
| GB1158954A (en) | N-(4-Carboxy-Phenyl)-Anthranilic Acid, derivatives thereof and a process for their preparation | |
| GB1287433A (en) | Pharmaceutical compositions | |
| GB1188109A (en) | Improvements in or relating to a novel Bis-(p-Chlorophenoxy)-Acetic Acid Ester | |
| GB1463260A (en) | Pharmacologically active acetic acid derivative | |
| GB1266430A (enrdf_load_stackoverflow) | ||
| GB779507A (en) | 4-acyl-3:5-dioxopyrazolidines and methods for the production thereof | |
| GB1310606A (en) | Adamantylcarboxamidophenylacetic acid derivatives their preparation and compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed | ||
| PCNP | Patent ceased through non-payment of renewal fee |